Glenmark Pharmaceuticals Ltd.

GLENMARK Share PricePharmaceuticals & Drugs

₹1,980.2

21 (1.1%)

As on October 3, 2025

Exchange Scrips: BSE532296NSEGLENMARKISININE935A01035

Market Cap ₹ 55,791 Cr

P/E Ratio 53.37

Dividend Yield 0.13 %

Performance

Market performance

Open1,959.2

High1,990

Volumes4,19,687

Prev1,980.2

Low1,950.2

As on2025-10-03

Historical performance

1 Year High2,284.8

3 Year High2,284.8

5 Year High2,284.8

1 Year Low1,275.5

3 Year Low369.05

5 Year Low348.5

Fundamentals

Company Valuation

Market Cap (₹Cr)

55,791

Face Value (₹)

P/E Ratio

53.37

Dividend Yield

0.13 %

Investment Returns

1 Year

20.4%

3 Years

393.9%

5 Years

303.3%

10 Years

90.9%

Technicals

Indicators	Value	Signal
5-DMA	1,964.4	Bullish
10-DMA	1,999.11	Bearish
20-DMA	2,046.48	Bearish
50-DMA	2,035.26	Bearish
100-DMA	1,868.78	Bullish
200-DMA	1,661.74	Bullish

Shareholding Pattern

Field	Jun-2025	Mar-2025	Dec-2024	Sep-2024	Jun-2024
Promoters	6	6	6	6	6
Foreign Investors	---	---	---	---	---
Domestic Investors	6	6	6	6	6
Public Investors	190204	192718	195053	193943	192624
Government	4	4	3	3	3

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

Negative

Neutral

Positive

The stock has a PE ratio of 53.37.
3Y Stock Price CAGR of the stock is 70.4.
The stock has a beta of 0.7.
In the last financial year, the company had an EBITDA of ₹24651 Million.
The company generated revenue of ₹133217 Million in the previous financial year.

Glenmark Pharmaceuticals Ltd.

1980.221 (1.1%)

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1182138.4

No. of Shares: 597 (Approx)

Performance:18.2%

P/L: ₹182138.4

Top Gainers